CARDIOGEVITY

Serial Number 98582875
688

Registration Progress

Application Filed
Jun 4, 2024
Under Examination
Mar 11, 2025
Approved for Publication
Jan 14, 2025
Published for Opposition
Jan 14, 2025
Registered

Attorney Assistance

Notice of Allowance Mailed - SOU Required
Due: Sep 11, 2025 39 days

Trademark Image

CARDIOGEVITY

Basic Information

Serial Number
98582875
Filing Date
June 4, 2024
Published for Opposition
January 14, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Mar 11, 2025
Application
Pending
Classes
005 042

Rights Holder

Rejuvenation Technologies Inc.

03
Address
415 Clyde Ave. Unit 107
Mountain View, CA 94043

Ownership History

Rejuvenation Technologies Inc.

Original Applicant
03
Mountain View, CA

Rejuvenation Technologies Inc.

Owner at Publication
03
Mountain View, CA

USPTO Deadlines

Next Deadline
39 days remaining
Notice of Allowance Mailed - SOU Required
Due Date
September 11, 2025
Extension Available
Until March 11, 2026

Application History

8 events
Date Code Type Description Documents
Mar 11, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 14, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 14, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 8, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 20, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 16, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 15, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 4, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Nutraceuticals for the treatment of or prevention of diseases and conditions related to short telomeres; Nutraceuticals for the treatment of or prevention of diseases and conditions of aging; Nutraceuticals for the treatment of or prevention of diseases and conditions of the heart; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions related to short telomeres; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions of aging; Pharmaceutical preparations for the treatment of heart conditions and diseases
Class 042
Research and development in the field of biotechnology; Research and development of medicines

Classification

International Classes
005 042